Patents by Inventor Andreas Michael TOSSTORFF

Andreas Michael TOSSTORFF has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HETEROCYCLIC NLRP3 INHIBITORS
    Publication number: 20240409553
    Abstract: The invention relates to novel compounds having the general formula Ib wherein R1, R1b, R2, R3, and Z are as described herein, composition including the compounds and methods of using the compounds.
    Type: Application
    Filed: May 15, 2024
    Publication date: December 12, 2024
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Lewis Scott AITKEN, Lea Aurelie BOUCHE, Wolfgang GUBA, Georg JAESCHKE, Stefanie Katharina MESCH, Sandra STEINER, Andreas Michael TOSSTORFF
  • PYRIDAZINE DERIVATIVES AS INHIBITORS OF NLRP3
    Publication number: 20240308977
    Abstract: The invention relates to novel compounds having the general formula Ib wherein RX, RY and Z is described herein, composition including the compounds and methods of using the compounds.
    Type: Application
    Filed: May 16, 2024
    Publication date: September 19, 2024
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Lewis Scott AITKEN, Thomas Alexander ALANINE, Lea Aurelie BOUCHE, Wolfgang GUBA, Georg JAESCHKE, Stefanie Katharina MESCH, Stephen Malcom THOM, Andreas Michael TOSSTORFF, Sabrina HERR, Christian SCHNIDER, Sandra STEINER
  • NOVEL COMPOUNDS
    Publication number: 20240208928
    Abstract: The invention relates to novel compounds having the general formula Ib wherein R1, R2, R3, R4, R5, and Z are as described herein, composition including the compounds and methods of using the compounds.
    Type: Application
    Filed: November 10, 2023
    Publication date: June 27, 2024
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Lea Aurelie BOUCHE, Wolfgang GUBA, Georg JAESCHKE, Stefanie Katharina MESCH, Andreas Michael TOSSTORFF
  • NOVEL COMPOUNDS
    Publication number: 20240132471
    Abstract: The invention relates to novel compounds having the general formula Ib wherein R1, R2, R1, R4, R5 and Z are as described herein, composition including the compounds and methods of using the compounds.
    Type: Application
    Filed: November 30, 2023
    Publication date: April 25, 2024
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Lea Aurelie BOUCHE, Wolfgang GUBA, Georg JAESCHKE, Stefanie Katharina MESCH, Angélique PATINY-ADAM, Christian SCHNIDER, Sandra STEINER, Andreas Michael TOSSTORFF